Cargando...
Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome
OBJECTIVE: The European Increlex(®) Growth Forum Database Registry monitors the effectiveness and safety of recombinant human insulin-like growth factor-1 (rhIGF1; mecasermin, Increlex(®)) therapy in patients with severe primary IGF1 deficiency (SPIGFD). We present data from patients with and withou...
Guardado en:
| Publicado en: | Eur J Endocrinol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Bioscientifica Ltd
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7849377/ https://ncbi.nlm.nih.gov/pubmed/33434161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EJE-20-0325 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|